Fierce Pharma Asia—Biocon, Viatris’ insulin biosim launch; AstraZeneca China’s deceleration; Huahai’s FDA warning lift aliu Fri, 11/19/2021 – […]
No surprises for PfizerThe phase II/III double-blind randomised controlled trial of Pfizer’s BNT162b2 vaccine in 5-11 year olds […]
The Global Health infrastructure is broken. We are attempting to put plasters on multiple compound fractures—a useless and […]
A nationwide network of family hubs should be put at the core of a national strategy on child […]
Clinicians are driven by a common mission: to optimally improve health, prevent harm, and advance equity. This means […]
More than 650 health experts and activists are calling on the government to back amendments in the forthcoming […]
Vumerity is a next-generation oral fumarate treatment for adults with relapsing-remitting multiple sclerosis
Eligible adult patients with primary or secondary myelofibrosis will now be able to access the treatment on the […]
Biogen’s Aduhelm ‘likely’ linked to Alzheimer’s patient’s death, RBC analyst says fkansteiner Thu, 11/18/2021 – 15:21